Literature DB >> 3111542

Immunological detection of low-density lipoproteins modified by malondialdehyde in vitro or in vivo.

S Salmon, C Maziere, L Theron, I Beucler, M Ayrault-Jarrier, S Goldstein, J Polonovski.   

Abstract

We describe an ELISA technique able to recognize malondialdehyde-modified low-density lipoproteins (LDL). For this purpose we produced antibodies to malondialdehyde-LDL, specific for the malondialdehyde modification of LDL; these antibodies recognized essentially malondialdehyde-LDL. Coating ELISA plates with the antibodies to malondialdehyde-LDL and using peroxidase-labelled antibodies to LDL, which reveal only apolipoprotein B, we obtained an accurate method of detecting malondialdehyde-modified apolipoprotein B. Preliminary studies demonstrated that this method allows the detection of lipoproteins containing malondialdehyde-modified apolipoprotein B in the serum of patients with cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3111542     DOI: 10.1016/0005-2760(87)90097-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Calcium-channel blockers inhibit human low-density lipoprotein oxidation by oxygen radicals.

Authors:  C Napoli; M Chiariello; G Palumbo; G Ambrosio
Journal:  Cardiovasc Drugs Ther       Date:  1996-09       Impact factor: 3.727

Review 2.  Antioxidant vitamins and prevention of cardiovascular disease: epidemiological and clinical trial data.

Authors:  R Marchioli; C Schweiger; G Levantesi; L Tavazzi; F Valagussa
Journal:  Lipids       Date:  2001       Impact factor: 1.880

3.  Preparation of LDL , Oxidation , Methods of Detection, and Applications in Atherosclerosis Research.

Authors:  Chandrakala Aluganti Narasimhulu; Sampath Parthasarathy
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Oxidized low-density lipoprotein.

Authors:  Sampath Parthasarathy; Achuthan Raghavamenon; Mahdi Omar Garelnabi; Nalini Santanam
Journal:  Methods Mol Biol       Date:  2010

5.  Intact human ceruloplasmin oxidatively modifies low density lipoprotein.

Authors:  E Ehrenwald; G M Chisolm; P L Fox
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

6.  Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochemical characterization and determination.

Authors:  Q Chen; H Esterbauer; G Jürgens
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

7.  Immunological approach to investigating membrane cell damages induced by lipoperoxidative stress. Application to far UV-irradiated erythrocytes.

Authors:  E Petit; D Divoux; Y Chancerelle; J F Kergonou; A Nouvelot
Journal:  Biol Trace Elem Res       Date:  1995 Jan-Mar       Impact factor: 3.738

8.  Presence of hypochlorite-modified proteins in human atherosclerotic lesions.

Authors:  L J Hazell; L Arnold; D Flowers; G Waeg; E Malle; R Stocker
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

Review 9.  Lipoproteins as targets and markers of lipoxidation.

Authors:  Catarina B Afonso; Corinne M Spickett
Journal:  Redox Biol       Date:  2018-12-06       Impact factor: 11.799

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.